• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测定治疗剂量后血清中奋乃静及其脱烷基代谢物的高效液相色谱法。

A high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses.

作者信息

Larsson M, Forsman A

出版信息

Ther Drug Monit. 1983 Jun;5(2):225-8. doi: 10.1097/00007691-198306000-00014.

DOI:10.1097/00007691-198306000-00014
PMID:6879648
Abstract

A new high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite is presented. The procedure is based on the use of thiethylperazine maleate as internal standard. Concentrations of perphenazine and its dealkylated metabolite could be analysed simultaneously in serum from patients being treated with the drug. The intraassay variability was 6.5% and 8.5% and the interassay variability 8.9% and 11.1% for drug and metabolite, respectively.

摘要

本文介绍了一种用于测定奋乃静及其脱烷基代谢物的新型高效液相色谱法。该方法以马来酸硫乙拉嗪作为内标。使用该药物治疗的患者血清中的奋乃静及其脱烷基代谢物的浓度能够同时进行分析。药物和代谢物的批内变异系数分别为6.5%和8.5%,批间变异系数分别为8.9%和11.1%。

相似文献

1
A high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses.一种用于测定治疗剂量后血清中奋乃静及其脱烷基代谢物的高效液相色谱法。
Ther Drug Monit. 1983 Jun;5(2):225-8. doi: 10.1097/00007691-198306000-00014.
2
Quantitative determination of perphenazine and its dealkylated metabolite using high-performance liquid chromatography.采用高效液相色谱法定量测定奋乃静及其脱烷基代谢物。
J Chromatogr. 1985 May 31;341(1):244-50. doi: 10.1016/s0378-4347(00)84037-2.
3
Determination of perphenazine and its sulphoxide metabolite in human plasma after therapeutic doses by gas chromatography.治疗剂量后气相色谱法测定人血浆中奋乃静及其亚砜代谢物
J Chromatogr. 1975 Jun 18;109(2):259-64. doi: 10.1016/s0021-9673(01)91797-2.
4
High-performance liquid chromatographic determination of perphenazine in plasma.
J Clin Pharm Ther. 1993 Jun;18(3):205-8. doi: 10.1111/j.1365-2710.1993.tb00614.x.
5
Liquid-chromatographic determination of propisomide and its mono-N-dealkylated metabolite in plasma and urine.血浆和尿液中丙匹西泮及其单-N-去烷基代谢物的液相色谱测定法。
Clin Chem. 1985 Jul;31(7):1222-4.
6
High-pressure liquid chromatographic analysis of drugs in biological fluids. III. Analysis of disopyramide and its mono-N-dealkylated metabolite in plasma and urine.
J Chromatogr. 1977 Feb 21;132(3):503-10. doi: 10.1016/s0021-9673(00)82914-3.
7
Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detection.高效液相色谱法结合库仑检测法定量测定血浆中奋乃静及其代谢产物
J Chromatogr B Biomed Appl. 1995 Jun 23;668(2):291-7. doi: 10.1016/0378-4347(95)00074-s.
8
Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma.UPLC-MS/MS 法同时检测血清和血浆中的传统抗精神病药氟哌啶醇、奋乃静、哌泊噻嗪和硫利达嗪
Clin Chim Acta. 2013 Aug 23;423:32-4. doi: 10.1016/j.cca.2013.04.014. Epub 2013 Apr 23.
9
Oral intake of perphenazine decanoate.口服癸酸奋乃静。
Ther Drug Monit. 1998 Dec;20(6):724. doi: 10.1097/00007691-199812000-00026.
10
Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.气相色谱法测定精神分裂症患者服用阿米替林与奋乃静联合制剂后血浆中阿米替林、去甲替林和奋乃静的含量。
Arzneimittelforschung. 1979;29(1):158-61.

引用本文的文献

1
A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.一项关于中枢D2受体占有率与血清奋乃静浓度之间关系的交叉验证研究。
Psychopharmacology (Berl). 2004 Sep;175(2):148-53. doi: 10.1007/s00213-004-1802-1. Epub 2004 Mar 6.
2
Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses.精神分裂症或相关精神病男性和女性患者中抗精神病药物的剂量需求及催乳素升高情况
Br J Clin Pharmacol. 2001 Apr;51(4):317-24. doi: 10.1046/j.1365-2125.2001.01352.x.
3
Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.
抗精神病药物。血浆浓度监测潜在候选药物的临床药代动力学。
Clin Pharmacokinet. 1987 Aug;13(2):65-90. doi: 10.2165/00003088-198713020-00001.
4
Plasma level monitoring of antipsychotic drugs. Clinical utility.抗精神病药物的血药浓度监测。临床应用。
Clin Pharmacokinet. 1986 Jan-Feb;11(1):36-61. doi: 10.2165/00003088-198611010-00003.